Professor Said Sebit brings significant drug discovery and cancer research experience to Prescient as the co-inventor of the Company’s two clinical stage oncology candidates. As the Chair of the Drug Discovery Department and Leader of the Chemical Biology and Molecular Medicine at the Moffitt Cancer Center and Research Institute, Professor Sebti is responsible for leading the Drug Discovery efforts at Moffitt including Chemistry, Structural Biology, pharmacology and for collaborating with physicians to translate such discoveries to clinic. Professor Sebti is also Professor of Oncological Sciences at the University of South Florida. He previously held positions at University of Pittsburgh School of Medicine as well as member of the University of Pittsburgh Cancer Institute. Professor Sebti earned a Ph.D. in biochemistry from Purdue University and a BS in Biochemistry from Washington State University. He conducted a post‐doctoral fellowship in pharmacology at Yale University.